Solvex Edibles IPO Allotment Status: Check Overall Subscription, Steps To Verify Status

The bidding window for the Solvex Edibles SME IPO was open from September 22, 2025, to September 26, 2025. The basis of allotment will be finalised today, September 29, 2025. Here’s how you can check the IPO allotment status. 

Procedure to Check Solvex Edibles IPO Allotment Status Online On BSE

• Click here to visit the application status page. 
• In Issue Type, “Equity”.
• In Issue Name, select “Solvex Edibles Limited”.
• Enter your “Application No.” or “PAN No.”
• Click on “I am not a robot”.
• Click “Submit”.

Procedure to Check Solvex Edibles IPO Allotment Status on Maashitla Securities (Registrar to the issue)

• Visit the Maashitla’s IPO allotment verification status page here. 
• Select “Solvex Edibles LIMITED” under “Please select company”.
• Enter any of the following details. 
• PAN
• Application Number
• Demat Account Number
• Click “Submit”.

IPO Details

The Solvex Edibles IPO is a fixed-price issue of ₹18.87 crores, consisting entirely of a fresh issue of ₹0.26 crore shares. The price band is set at ₹72 per share. The tentative listing on the BSE SME is scheduled for September 29, 2025. 

Corporate Makers Capital Ltd. is the book-running lead manager, and Maashitla Securities is the registrar for the issue. 

Use of Proceeds

The net proceeds from the fresh issue will be used to: 

• Finance the capital expenditure for the acquisition of new plant and machinery. 
• Repayment/prepayment of outstanding borrowings 
• General corporate purposes 

Solvex Edibles IPO – Overall Subscription Status

(September 26, 2025, end of the day)

Solvex Edibles Business Overview

Solvex Edibles specialises in the manufacturing, supply, and distribution of solvent-extracted rice bran oil along with a variety of related by-products, including de-oiled cakes derived from rice bran and mustard, rice bran, mustard oil, and mustard cakes. Their manufacturing facility is located in Kemri, District Bilaspur, Uttar Pradesh. 

Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory. 

To read the RA disclaimer, please click here.